Patents by Inventor Karen Louise Philpott

Karen Louise Philpott has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES
    Publication number: 20170210748
    Abstract: This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2 and R3 are as defined herein, and their use as pharmaceuticals.
    Type: Application
    Filed: January 30, 2017
    Publication date: July 27, 2017
    Inventors: David R. WITTY, David NORTON, Jason Paul TIERNEY, Ghislaine LORTHIOIR, Mairi SIME, Karen Louise PHILPOTT
  • ASK1 inhibiting pyrrolopyrimidine derivatives
    Patent number: 9585886
    Abstract: This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2 and R3 are as defined herein, and their use as pharmaceuticals.
    Type: Grant
    Filed: April 28, 2015
    Date of Patent: March 7, 2017
    Assignee: Calchan Limited
    Inventors: David R. Witty, David Norton, Jason Paul Tierney, Ghislaine Lorthioir, Mairi Sime, Karen Louise Philpott
  • ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES
    Publication number: 20160067251
    Abstract: This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2 and R3 are as defined herein, and their use as pharmaceuticals.
    Type: Application
    Filed: April 28, 2015
    Publication date: March 10, 2016
    Inventors: David R. WITTY, David Norton, Jason Paul Tierney, Ghislaine Lorthioir, Mairi Sime, Karen Louise Philpott
  • ANTIBODIES AGAINST AMYLOID-BETA PEPTIDE
    Publication number: 20160024197
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Application
    Filed: October 13, 2015
    Publication date: January 28, 2016
    Inventors: Stephen Anthony BURBIDGE, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski
  • Antibodies
    Patent number: 9193784
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterized by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Grant
    Filed: June 8, 2012
    Date of Patent: November 24, 2015
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ASK 1 inhibiting pyrrolopyrimidine derivatives
    Patent number: 9045485
    Abstract: This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2 and R3 are as defined herein, and their use as pharmaceuticals.
    Type: Grant
    Filed: December 15, 2011
    Date of Patent: June 2, 2015
    Assignee: CONVERGENCE PHARMACEUTICALS LIMITED
    Inventors: David R. Witty, David Norton, Jason Paul Tierney, Ghislaine Lorthioir, Mairi Sime, Karen Louise Philpott
  • Antigen binding proteins
    Patent number: 8858943
    Abstract: The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterized by elevated ?-amyloid levels or ?-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with antigen binding proteins that bind ?-amyloid peptide and in particular human ?-amyloid peptide.
    Type: Grant
    Filed: September 23, 2008
    Date of Patent: October 14, 2014
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ANTIBODIES
    Publication number: 20140050719
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Application
    Filed: June 8, 2012
    Publication date: February 20, 2014
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K. Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ASK 1 INHIBITING PYRROLOPYRIMIDINE DERIVATIVES
    Publication number: 20140038957
    Abstract: This invention relates to pyrrolopyrimidine derivatives of formula (I): where R1, X, p, R4, R2 and R3 are as defined herein, and their use as pharmaceuticals.
    Type: Application
    Filed: December 15, 2011
    Publication date: February 6, 2014
    Inventors: David R. Witty, David Norton, Jason Paul Tierney, Ghislaine Lorthioir, Mairi Sime, Karen Louise Philpott
  • Antibodies against amyloid-? peptide
    Patent number: 8227576
    Abstract: Antibodies that bind human ?-amyloid peptide, methods of treating diseases or disorders characterised by elevated ?-amyloid levels or ?-amyloid deposits with said antibodies, pharmaceutical compositions comprising said antibodies and methods of manufacture.
    Type: Grant
    Filed: March 27, 2007
    Date of Patent: July 24, 2012
    Assignee: Glaxo Group Limited
    Inventors: Stephen Anthony Burbidge, Jonathan Henry Ellis, Susannah K Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden
  • ANTIGEN BINDING PROTEINS
    Publication number: 20110064740
    Abstract: The present invention relates to methods of treating diseases or disorders affecting the eye or optic nerve characterised by elevated ?-amyloid levels or ?-amyloid deposits, particularly age related macular degeneration and glaucoma type diseases and ?-amyloid dependent cataract formation, with antigen binding proteins that bind ?-amyloid peptide and in particular human ?-amyloid peptide.
    Type: Application
    Filed: September 23, 2008
    Publication date: March 17, 2011
    Inventors: Stephen Anthony Burbidge, Ian Richard Catchpole, Jonathan Henry Ellis, Susannah Karen Ford, Volker Germaschewski, Umesh Kumar, Karen Louise Philpott, Peter Ernest Soden